Skip to navigationSkip to content

Makers of top-selling drugs hike prices in lockstep, and patients bear the cost - STAT

By STAT

The makers of two arthritis drugs increased their prices in lockstep from 2013-2018, reflecting their clout in a market where patients suffer blinding painRead full story

Comments

Want more conversations like this?

Join the Quartz community for all the intelligence, without the noise.

App Store BadgeGoogle Play Badge
Leaderboard Screenshot

A community of leaders, subject matter experts, and curious minds bringing nuance back to how we talk about the news.

Editors' Picks Screenshot

No content overload: our editors will curate the most notable and discussion-worthy pieces for you every day.

Share Screenshot

Don’t just read the story, tell it: contribute your ideas and experience to the dialogue.